EPO Patents = 3

Forward Citations = 0

Loading Chart...

5 inventors (with patents filed for the assignee):

Arie Pieter Otte (5 out of 26 patents)

John Antonius Verhees (5 out of 5 patents)

Henricus Johannes Maria Van Blokland (5 out of 9 patents)

4. Femke Hoeksema (3 out of 3 patents)

5. Michel Siep (2 out of 2 patents)

5 patents: Sort by Forward Citations

1. 10563223 - Intergenic elements for enhancing gene expression (2020-02-18),

2. 10106799 - Stringent selectable markers (2018-10-23),

3. 9790517 - Intergenic elements for enhancing gene expression (2017-10-17),

4. 9650630 - Nucleic acid fragments from a ribosomal protein promoter for enhancing gene expression (2017-05-16),

5. 9284563 - Stringent selectable markers (2016-03-15),

Cellagenics B.v. is a leading biotechnology company specializing in the research, development, and production of cell therapy products. With a focus on regenerative medicine, the company is dedicated to advancing innovative cellular therapies for various medical conditions. Through cutting-edge technology and scientific expertise, Cellagenics is committed to improving patient outcomes and quality of life.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Jan 20 2026

5 Patents

#98 in Amsterdam

#1,106 in Netherlands

Amsterdam, Netherlands

Cellagenics B.v.